Restoration of APC gene function in colorectal cancer cells by aminoglycoside- and macrolide-induced read-through of premature termination codons

Gut

Volumn 59, Issue 4, 2010, Pages 496-507

  Zilberberg, Alona ^a   Lahav, Lital ^a   Rosin Arbesfeld, Rina ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; MACROLIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; COLON POLYPOSIS; COLORECTAL CANCER; CONTROLLED STUDY; GENE FUNCTION; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; NONSENSE MUTATION; PLASMID; PRIORITY JOURNAL; TUMOR XENOGRAFT;

AMINOGLYCOSIDES; ANIMALS; ANTINEOPLASTIC AGENTS; CODON, NONSENSE; COLORECTAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, APC; HUMANS; MACROLIDES; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, NUDE; TUMOR CELLS, CULTURED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 77950837290     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gut.2008.169805     Document Type: Article

References (63)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2006. CA Cancer J Clin 2006;56:106-130
2. Fearnhead NS, Britton MP, Bodmer WF. The ABC of APC. Hum Mol Genet 2001;10:721-733
3. Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell 1996;87:159-170
4. Aoki K, Taketo MM. Adenomatous polyposis coli (APC): a multi-functional tumor suppressor gene. J Cell Sci 2007;120:3327-3335 (Pubitemid 350028340)
5. Rubinfeld B, Souza B, Albert I, et al. Association of the APC gene product with beta-catenin. Science 1993;262:1731-1734 (Pubitemid 24030096)
6. Su LK, Vogelstein B, Kinzler KW. Association of the APC tumor suppressor protein with catenins. Science 1993;262:1734-1737 (Pubitemid 24030097)
7. Hirohashi S, Kanai Y. Cell adhesion system and human cancer morphogenesis. Cancer Sci 2003;94:575-581 (Pubitemid 36975010)
8. Hamada F, Bienz M. A Drosophila APC tumour suppressor homologue functions in cellular adhesion. Nat Cell Biol 2002;4:208-213 (Pubitemid 34218194)
9. Faux MC, Ross JL, Meeker C, et al. Restoration of full-length adenomatous polyposis coli (APC) protein in a colon cancer cell line enhances cell adhesion. J Cell Sci 2004;117:427-439 (Pubitemid 38181204)
10. Kaplan KB, Burds AA, Swedlow JR, et al. A role for the Adenomatous Polyposis Coli protein in chromosome segregation. Nat Cell Biol 2001;3:429-432
11. Fodde R, Kuipers J, Rosenberg C, et al. Mutations in the APC tumour suppressor gene cause chromosomal instability. Nat Cell Biol 2001;3:433-438 (Pubitemid 32288454)
12. Votin V, Nelson WJ, Barth AI. Neurite outgrowth involves adenomatous polyposis coli protein and beta-catenin. J Cell Sci 2005;118:5699-5708 (Pubitemid 43079264)
13. Kawasaki Y, Sato R, Akiyama T. Mutated APC and Asef are involved in the migration of colorectal tumour cells. Nat Cell Biol 2003;5:211-215 (Pubitemid 36322247)
14. Beroud C, Soussi T. APC gene: database of germline and somatic mutations in human tumors and cell lines. Nucleic Acids Res 1996;24:121-124 (Pubitemid 26085747)
15. Atkinson J, Martin R. Mutations to nonsense codons in human genetic disease: implications for gene therapy by nonsense suppressor tRNAs. Nucleic Acids Res 1994;22:1327-1334 (Pubitemid 24166827)
16. Purohit P, Stern S. Interactions of a small RNA with antibiotic and RNA ligands of the 30S subunit. Nature 1994;370:659-662 (Pubitemid 24270688)
17. Lynch SR, Gonzalez RL, Puglisi JD. Comparison of X-ray crystal structure of the 30S subunit-antibiotic complex with NMR structure of decoding site oligonucleotide-paromomycin complex. Structure 2003;11:43-53.
18. Davies J, Gilbert W, Gorini L. Streptomycin, suppression, and the code. Proc Natl Acad Sci U S A 1964;51:883-890
19. Burke JF, Mogg AE. Suppression of a nonsense mutation in mammalian cells in vivo by the aminoglycoside antibiotics G-418 and paromomycin. Nucleic Acids Res 1985;13:6265-6272
20. Martin R, Mogg AE, Heywood LA, et al. Aminoglycoside suppression at UAG, UAA and UGA codons in Escherichia coli and human tissue culture cells. Mol Gen Genet 1989;217:411-418
21. Bidou L, Hatin I, Perez N, et al. Premature stop codons involved in muscular dystrophies show a broad spectrum of readthrough efficiencies in response to gentamicin treatment. Gene Ther 2004;11:619-627 (Pubitemid 38455980)
22. Manuvakhova M, Keeling K, Bedwell DM. Aminoglycoside antibiotics mediate context-dependent suppression of termination codons in a mammalian translation system. RNA 2000;6:1044-1055 (Pubitemid 30471140)
23. Keeling KM, Bedwell DM. Clinically relevant aminoglycosides can suppress disease-associated premature stop mutations in the IDUA and P53 cDNAs in a mammalian translation system. J Mol Med 2002;80:367-376
24. McCaughan KK, Brown CM, Dalphin ME, et al. Translational termination efficiency in mammals is influenced by the base following the stop codon. Proc Natl Acad Sci U S A 1995;92:5431-5435
25. Howard M, Frizzell RA, Bedwell DM. Aminoglycoside antibiotics restore CFTR function by overcoming premature stop mutations. Nat Med 1996;2:467-469 (Pubitemid 26191920)
26. Bedwell DM, Kaenjak A, Benos DJ, et al. Suppression of a CFTR premature stop mutation in a bronchial epithelial cell line. Nat Med 1997;3:1280-1284 (Pubitemid 27508832)
27. Barton-Davis ER, Cordier L, Shoturma DI, et al. Aminoglycoside antibiotics restore dystrophin function to skeletal muscles of mdx mice. J Clin Invest 1999;104:375-381 (Pubitemid 29534321)
28. Maire I. Is genotype determination useful in predicting the clinical phenotype in lysosomal storage diseases? J Inherit Metab Dis 2001;24 Suppl 2:57-61; discussion 45-46
29. Hainrichson M, Nudelman I, Baasov T. Designer aminoglycosides: the race to develop improved antibiotics and compounds for the treatment of human genetic diseases. Org Biomol Chem 2008;6:227-239
30. Thompson J, Pratt CA, Dahlberg AE. Effects of a number of classes of 50S inhibitors on stop codon readthrough during protein synthesis. Antimicrob Agents Chemother 2004;48:4889-4891 (Pubitemid 39577701)
31. Sohn KJ, Puchyr M, Salomon RN, et al. The effect of dietary folate on Apc and p53 mutations in the dimethylhydrazine rat model of colorectal cancer. Carcinogenesis 1999;20:2345-2350 (Pubitemid 30015910)
32. Dietrich WF, Lander ES, Smith JS, et al. Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse. Cell 1993;75:631-639
33. Al-Nasiry S, Geusens N, Hanssens M, et al. The use of Alamar Blue assay for quantitative analysis of viability, migration and invasion of choriocarcinoma cells. Hum Reprod 2007;22:1304-1309 (Pubitemid 47062799)
34. Toyooka M, Konishi M, Kikuchi-Yanoshita R, et al. Somatic mutations of the adenomatous polyposis coli gene in gastroduodenal tumors from patients with familial adenomatous polyposis. Cancer Res 1995;55:3165-3170
35. Sieber OM, Tomlinson IP, Lamlum H. The adenomatous polyposis coli (APC) tumour suppressoregenetics, function and disease. Mol Med Today 2000;6:462-469
36. Salas-Marco J, Bedwell DM. Discrimination between defects in elongation fidelity and termination efficiency provides mechanistic insights into translational readthrough. J Mol Biol 2005;348:801-815 (Pubitemid 40544383)
37. Rowan AJ, Lamlum H, Ilyas M, et al. APC mutations in sporadic colorectal tumors: A mutational "hotspot" and interdependence of the "two hits". Proc Natl Acad Sci U S A 2000;97:3352-3357
38. Trainer DL, Kline T, McCabe FL, et al. Biological characterization and oncogene expression in human colorectal carcinoma cell lines. Int J Cancer 1988;41:287-296 (Pubitemid 18061157)
39. Gumbiner BM. Regulation of cadherin-mediated adhesion in morphogenesis. Nat Rev Mol Cell Biol 2005;6:622-634
40. Okegawa T, Pong RC, Li Y, et al. The role of cell adhesion molecule in cancer progression and its application in cancer therapy. Acta Biochim Pol 2004;51:445-457 (Pubitemid 38969306)
41. Nakayama GR, Caton MC, Nova MP, et al. Assessment of the Alamar Blue assay for cellular growth and viability in vitro. J Immunol Methods 1997;204:205-208 (Pubitemid 27262014)
42. Breitman M, Zilberberg A, Caspi M, et al. The armadillo repeat domain of the APC tumor suppressor protein interacts with Striatin family members. Biochim Biophys Acta 2008;1783:1792-1802
43. Sheng H, Shao J, Kirkland SC, et al. Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2. J Clin Invest 1997;99:2254-2259 (Pubitemid 27203783)
44. Moser AR, Pitot HC, Dove WF. A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science 1990;247:322-324 (Pubitemid 20046457)
45. Su LK, Kinzler KW, Vogelstein B, et al. Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science 1992;256:668-670
46. Unit VME. Tylosin. London: The European Agency for the Evaluation of Medicinal Products.
47. Orner GA, Dashwood WM, Blum CA, et al. Suppression of tumorigenesis in the Apc (min) mouse: down-regulation of beta-catenin signaling by a combination of tea plus sulindac. Carcinogenesis 2003;24:263-267
48. Liu M, Douthwaite S. Resistance to the macrolide antibiotic tylosin is conferred by single methylations at 23S rRNA nucleotides G748 and A2058 acting in synergy. Proc Natl Acad Sci U S A 2002;99:14658-14663 (Pubitemid 35334540)
49. Warmann SW, Fuchs J, Seitz G, et al. New trends in tumor biology: transfection of a human hepatoblastoma cell line with green fluorescent protein. J Pediatr Surg 2005;40:653-657 (Pubitemid 40504009)
50. Miyoshi Y, Nagase H, Ando H, et al. Somatic mutations of the APC gene in colorectal tumors: mutation cluster region in the APC gene. Hum Mol Genet 1992;1:229-233
51. McCormick F. Cancer gene therapy: fringe or cutting edge? Nat Rev Cancer 2001;1:130-141
52. Welch EM, Barton ER, Zhuo J, et al. PTC124 targets genetic disorders caused by nonsense mutations. Nature 2007;447:87-91. (Pubitemid 46685839)
53. Howard MT, Shirts BH, Petros LM, et al. Sequence specificity of aminoglycoside-induced stop condon readthrough: potential implications for treatment of Duchenne muscular dystrophy. Ann Neurol 2000;48:164-169
54. Hirohashi S. Inactivation of the E-cadherin-mediated cell adhesion system in human cancers. Am J Pathol 1998;153:333-339 (Pubitemid 28373643)
55. Kaufman RJ. Correction of genetic disease by making sense from nonsense. J Clin Invest 1999;104:367-368 (Pubitemid 29534318)
56. Weng Y, Czaplinski K, Peltz SW. Identification and characterization of mutations in the UPF1 gene that affect nonsense suppression and the formation of the Upf protein complex but not mRNA turnover. Mol Cell Biol 1996;16:5491-5506 (Pubitemid 26315069)
57. Wang W, Czaplinski K, Rao Y, et al. The role of Upf proteins in modulating the translation read-through of nonsense-containing transcripts. EMBO J 2001;20:880-890 (Pubitemid 32167652)
58. Amrani N, Ganesan R, Kervestin S, et al. A faux 3′-UTR promotes aberrant termination and triggers nonsense-mediated mRNA decay. Nature 2004;432:112-118 (Pubitemid 39490837)
59. Arakawa M, Shiozuka M, Nakayama Y, et al. Negamycin restores dystrophin expression in skeletal and cardiac muscles of mdx mice. J Biochem 2003;134:751-758 (Pubitemid 38031275)
60. Allamand V, Bidou L, Arakawa M, et al. Drug-induced readthrough of premature stop codons leads to the stabilization of laminin alpha2 chain mRNA in CMD myotubes. J Gene Med 2008;10:217-224 (Pubitemid 351267163)
61. Carter AP, Clemons WM, Brodersen DE, et al. Functional insights from the structure of the 30S ribosomal subunit and its interactions with antibiotics. Nature 2000;407:340-348
62. Ogle JM, Carter AP, Ramakrishnan V. Insights into the decoding mechanism from recent ribosome structures. Trends Biochem Sci 2003;28:259-266 (Pubitemid 36588668)
63. Tejedor F, Ballesta JP. Reaction of some macrolide antibiotics with the ribosome. Labeling of the binding site components. Biochemistry 1986;25:7725-7731